Used in advanced pharmaceutical research as a potential inhibitor in inflammatory and autoimmune disease pathways. Its complex polycyclic structure enables selective interaction with specific enzyme targets, particularly in modulating cellular signaling involved in immune response. Due to its high steric hindrance and stability imparted by multiple isopropyl and siloxane groups, it shows improved metabolic resistance, making it a candidate for oral drug development. Also explored in prodrug designs where the benzamide and pyrimidinone moieties allow for tunable solubility and target binding. Currently under investigation for preclinical evaluation in dermatological and rheumatological conditions.